Ligand validation:5HXI

5HN: 5-hydroxypyridine-3-carboxylic acid

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5HXI_5HN_A_403	30%	17%	0.195	0.859	2.18	1.47	3	4	7	0	100%	0.55
4H2Q_5HN_A_403	17%	18%	0.222	0.796	2.09	1.49	3	4	0	0	100%	0.43
4H2R_5HN_A_403	9%	13%	0.282	0.771	2.19	1.79	5	4	0	0	100%	1
5RST_5HN_A_201	7%	7%	0.288	0.749	3.32	1.5	1	1	1	0	100%	0.55

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.